Scheme of Amalgamation of Sesa Care Private Limited with Dabur India Limited and their respective shareholders and creditors under section 230 to 232 of the Companies Act, 2013. In compliance with Regulation 30 read with Schedule III of the Listing Regulations, we wish to inform you that the Board of Directors ('Board') of Dabur India Limited ('Company' or 'Transferee Company'), based on recommendations of the Audit Committee and the Independent Directors, at their meeting held today i. e. May 26, 2025, has inter alia considered and approved the scheme of amalgamation of Sesa Care Private Limited ('Transferor Company') with and into the Company and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions ofthe Companies Act, 2013 read with rules made thereunder ('Scheme'). The Scheme inter alia provides for the amalgamation of the Transferor Company with and into the Company Receipt of Observation Letter with 'no objection' from the NSE in relation to the Scheme of Amalgamation of Sesa Care Private Limited with and into Dabur India Limited and their respective shareholders and creditors. Please find attached Observation Letter with ''no adverse observations'' received from BSE Limited in relation to the Scheme of Amalgamation of Sesa Care Private Limited with and into Dabur India Limited (As Per BSE Announcement Dated on 05.12.2025) The Company is in receipt of Order dated March 12, 2026, passed by the Hon''ble National Company Law Tribunal, New Delhi Bench ('NCLT') for inter alia convening meeting of the equity shareholders and unsecured creditors of Dabur India Limited in connection with the scheme of Amalgamation between Dabur India Limited and Sesa Care Private Limited. (As per BSE Announcement dated on: 13.03.2026)